Neuroone Medical Technologies Corp Cash Flow Reinvestment Rate
Neuroone Medical Technologies Corp cash flow reinvestment rate. Neuroone Medical Technologies Corp (NMTC) has a Cash Flow Reinvestment Rate of 0.23x as of December 2024, reinvesting $48.83K (capex $24.42K plus investments $-24.42K) from operating cash flow of $208.05K. Explore Neuroone Medical Technologies Corp cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Neuroone Medical Technologies Corp (2009–2009)
Cash flow reinvestment rate of Neuroone Medical Technologies Corp from 2009 to 2009. Historical reinvestment intensity for Neuroone Medical Technologies Corp across 1 annual periods. Explore capital reinvestment ratio of Neuroone Medical Technologies Corp to see what proportion of operating cash flow is directed to capital expenditures.
Neuroone Medical Technologies Corp Cash Flow Reinvestment Rate by Year (2009–2009)
Neuroone Medical Technologies Corp cash flow reinvestment rate by year from 2009 to 2009. Year-by-year capital reinvestment analysis for Neuroone Medical Technologies Corp. For the full cash flow conversion analysis, see NMTC operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2009 | 0.00x | $0.00 | $6.18K | $0.00 | — |